139 related articles for article (PubMed ID: 7357745)
21. Immunoreactive prostatic acid phosphatase in prostatic cancer: diagnosis and followup of patients.
Vihko P; Kontturi M; Lukkarinen O; Vihko R
J Urol; 1985 Jun; 133(6):979-82. PubMed ID: 3999224
[TBL] [Abstract][Full Text] [Related]
22. Comparison of radioimmunoassay and immunoradiometric assay for serum prostatic acid phosphatase.
Sturgeon CM; Hussey AJ; Beynon L; Ritchie A; Chisholm GD; Micklem L; James K; Seth J
Clin Chim Acta; 1986 Nov; 161(1):47-57. PubMed ID: 2434268
[TBL] [Abstract][Full Text] [Related]
23. [Clinical evaluation and measurement of plasma prostatic acid phosphatase by solid phase enzyme immunoassay].
Okabe H; Noma A; Nakauchi K; Mori M
Rinsho Byori; 1986 Jul; 34(7):805-10. PubMed ID: 2428995
[No Abstract] [Full Text] [Related]
24. The evaluation of a new enzyme immunoassay for the measurement of prostatic acid phosphatase.
Cooper EH; Glashan R; Robinson MR; Morgan DB; Trautner K
Clin Chim Acta; 1981 Jun; 113(1):27-34. PubMed ID: 6165505
[TBL] [Abstract][Full Text] [Related]
25. Secretion into and elimination from blood circulation of prostate specific acid phosphatase, measured by radioimmunoassay.
Vihko P; Schroeder FH; Lukkarinen O; Vihko R
J Urol; 1982 Jul; 128(1):202-4. PubMed ID: 6180187
[TBL] [Abstract][Full Text] [Related]
26. [Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer].
Akimoto S; Akakura K; Shimazaki J
Hinyokika Kiyo; 1988 Aug; 34(8):1389-96. PubMed ID: 2461644
[TBL] [Abstract][Full Text] [Related]
27. Expression of prostatic acid phosphatase in human prostate cancer.
Loor R; Wang MC; Valenzuela L; Chu TM
Cancer Lett; 1981 Oct; 14(1):63-9. PubMed ID: 7296542
[TBL] [Abstract][Full Text] [Related]
28. A critical evaluation of a specific radioimmunoassay for prostatic acid phosphatase.
Goldenberg SL; Silver HK; Sullivan LD; Morse MJ; Archibald EL
Cancer; 1982 Nov; 50(9):1847-51. PubMed ID: 7116309
[TBL] [Abstract][Full Text] [Related]
29. Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.
Kuriyama M; Loor R; Wang MC; Lee C; Killian CS; Papsidero LD; Inaji H; Nishiura T; Slack NH; Murphy GP; Chu TM
Int Adv Surg Oncol; 1982; 5():29-49. PubMed ID: 6178696
[No Abstract] [Full Text] [Related]
30. Double-antibody immunoenzyme assay for human prostatic acid phosphatase.
Choe BK; Pontes EJ; Dong MK; Rose NR
Clin Chem; 1980 Dec; 26(13):1854-9. PubMed ID: 6159996
[TBL] [Abstract][Full Text] [Related]
31. [What is the use of the radioimmunoassay of prostatic acid phosphatase?].
Luckacs B; Cohen L; Coloby P; Gattegno B; Michel F; Agnes E; Roland J; Thibault P
J Urol (Paris); 1985; 91(4):211-4. PubMed ID: 2410516
[TBL] [Abstract][Full Text] [Related]
32. Clinical usefulness of prostate-specific antigen and prostatic acid phosphatase in patients with prostatic cancer.
Filella X; Molina R; Jo J; Umbert B; Bedini JL; Ballesta AM
Tumour Biol; 1990; 11(6):289-94. PubMed ID: 1700860
[TBL] [Abstract][Full Text] [Related]
33. Immunochemical studies of prostatic acid phosphatase.
Choe BK; Pontes EJ; McDonald I; Rose NR
Cancer Treat Rep; 1977; 61(2):201-4. PubMed ID: 68823
[TBL] [Abstract][Full Text] [Related]
34. Characterization of secretion pattern of human prostatic acid phosphatase: a reassessment.
Dejter SW; Erickson BA; Lynch JH
Urology; 1988 Feb; 31(2):125-8. PubMed ID: 3341096
[TBL] [Abstract][Full Text] [Related]
35. [Clinical evaluation of serum prostatic acid phosphatase assay based on the immunoenzymatic method (TZR-516)].
Ikemoto I; Machida T; Oishi Y; Onishi T; Shirai T; Imanaka K
Hinyokika Kiyo; 1989 Sep; 35(9):1639-42. PubMed ID: 2479240
[TBL] [Abstract][Full Text] [Related]
36. Circadian and day-to-day variation of prostatic acid phosphatase.
Nissenkorn I; Mickey DD; Miller DB; Soloway MS
J Urol; 1982 Jun; 127(6):1122-4. PubMed ID: 6177878
[TBL] [Abstract][Full Text] [Related]
37. [Determination of acid phosphatase in prostatic carcinoma].
Bauer HW; Walther V; Schmiedt F
Fortschr Med; 1980 Sep; 98(34):1301-5. PubMed ID: 7461538
[TBL] [Abstract][Full Text] [Related]
38. [Measurements of prostatic acid phosphatase and prostate specific antigen by fully automated enzyme immunoassay system--its analytical and clinical evaluation].
Matui A; Yamada T; Sugita O; Yakata M
Rinsho Byori; 1990 Jun; 38(6):693-8. PubMed ID: 1696328
[TBL] [Abstract][Full Text] [Related]
39. Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase.
Foti AG; Cooper JF; Herschman H; Malvaez RR
N Engl J Med; 1977 Dec; 297(25):1357-61. PubMed ID: 73133
[TBL] [Abstract][Full Text] [Related]
40. [Clinical evaluation of serum prostatic specific antigen in prostatic cancer: simultaneous assays of prostatic specific antigen, gamma-seminoprotein and prostatic acid phosphatase in 113 newly diagnosed patients with prostatic cancer].
Arai Y; Yoshki T; Okada K; Yoshida O; Yamamoto N; Sakatoku J; Sugimura Y; Kawamura J
Hinyokika Kiyo; 1989 Sep; 35(9):1519-28. PubMed ID: 2479237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
